https://www.selleckchem.com/pr....oducts/cinchocaine.h
1 to 3.9 ( .001). FAOSs improved postoperatively with regard to pain ( .001), symptoms ( = .001), quality of life ( .001), and activities of daily living ( .001). There were 3 complications requiring reoperation in this cohort. 3D printed TTRs represent a unique surgical option for patients with severe talar AVN. Patients in this cohort demonstrated significant improvements in pain scores and patient-reported outcomes. TTR allows for symptomatic improvement with the preservation of motion in individuals with tala
Like
Comment
Share
